StemRIM (TSE:4599) Scaled Net Operating Assets : 0.06 (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is StemRIM Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

StemRIM's operating assets for the quarter that ended in Jan. 2024 was 円876 Mil. StemRIM's operating liabilities for the quarter that ended in Jan. 2024 was 円243 Mil. StemRIM's Total Assets for the quarter that ended in Oct. 2023 was 円10,225 Mil. Therefore, StemRIM's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2024 was 0.06.

StemRIM Scaled Net Operating Assets Historical Data

The historical data trend for StemRIM's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Scaled Net Operating Assets Chart

StemRIM Annual Data

Trend

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.06

0.07

0.05

0.02

StemRIM Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.05	0.32	0.01	0.02	0.06

Competitive Comparison of StemRIM's Scaled Net Operating Assets

For the Biotechnology subindustry, StemRIM's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemRIM's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where StemRIM's Scaled Net Operating Assets falls into.

StemRIM Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

StemRIM's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jul. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jul. 2023 )
=	(Operating Assets (A: Jul. 2023 )	-	Operating Liabilities (A: Jul. 2023 ))	/	Total Assets (A: Jul. 2022 )
=	(488.718	-	335.493)	/	9597.373
=	0.02

where

	Operating Assets		(A: Jul. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	10706.482	-	10217.764
=	488.718

	Operating Liabilities		(A: Jul. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	336.024	-	0	-	0.531
=	335.493

StemRIM's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jan. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jan. 2024 )
=	(Operating Assets (Q: Jan. 2024 )	-	Operating Liabilities (Q: Jan. 2024 ))	/	Total Assets (Q: Oct. 2023 )
=	(876.234	-	242.671)	/	10225.286
=	0.06

where

	Operating Assets		(Q: Jan. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	10060.174	-	9183.94
=	876.234

	Operating Liabilities		(Q: Jan. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	242.671	-	0	-	0
=	242.671

StemRIM Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of StemRIM's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

StemRIM (TSE:4599) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085

Website

https://www.stemrim.com

StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines